WO2000029848A1 - Separation, tri et identification de cibles biologiques - Google Patents

Separation, tri et identification de cibles biologiques Download PDF

Info

Publication number
WO2000029848A1
WO2000029848A1 PCT/US1999/027192 US9927192W WO0029848A1 WO 2000029848 A1 WO2000029848 A1 WO 2000029848A1 US 9927192 W US9927192 W US 9927192W WO 0029848 A1 WO0029848 A1 WO 0029848A1
Authority
WO
WIPO (PCT)
Prior art keywords
molecules
target
biological
screening
interaction
Prior art date
Application number
PCT/US1999/027192
Other languages
English (en)
Other versions
WO2000029848A9 (fr
Inventor
James T. Champagne
Original Assignee
Proteo Tools
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteo Tools filed Critical Proteo Tools
Priority to AU20254/00A priority Critical patent/AU2025400A/en
Publication of WO2000029848A1 publication Critical patent/WO2000029848A1/fr
Publication of WO2000029848A9 publication Critical patent/WO2000029848A9/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00—Magnetic separation
    • B03C1/005—Pretreatment specially adapted for magnetic separation
    • B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44756—Apparatus specially adapted therefor
    • G01N27/44773—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis

Definitions

  • the invention relates to a method and apparatus for the isolation, characterizing, screening, recombining and interacting of biological molecules such as proteins, peptides, nucleic acids and ligands so as to analyze various biological activities of these molecules individually or on a global scale. Moreover the invention relates to the positional mapping of isolated biological molecules in multiple solution- based separation means so as to provide a unique set of identifying characteristics for each biological molecule. The invention further relates to the utilization of this information for the simultaneous screening, selection and enrichment of interactive ligands, substrates or other interactive molecules in many thousands of parallel ligand-target, substrate-enzyme or other biological interactions. The invention further relates to identification and display of the target molecules or interactive molecules for subsequent analysis.
  • biological molecules such as proteins, peptides, nucleic acids and ligands
  • Two dimensional gel electrophoresis is one of these global techniques for analyzing multiple proteins.
  • Recent research, using two dimensional gel electrophoresis, has attempted to analyze the predictability of the gene expression data from Functional Genomics for determining protein mass in a whole cell.
  • a good discussion of how comprehensive these current 2D gel methods are at measuring all of the expressed proteins in a cell at a given moment is in "Correlation between Protein and mRNA Abundance in Yeast" Gygi et al. Molecular and Cellular Biology 79:3 p1720-1730 (1999). The article demonstrates that in the eukaryotic organism S.
  • New techniques are providing fast and sensitive methods for pairwise comparison of the relative abundance of a given protein under different conditions (Nature Biotechnology 17, 994-999 (1999) for example), but do not give a global picture of biological activity changes.
  • the means of analysis in the current invention, depends on a predetermined positional mapping in multiple separation parameters down to the lowest abundance, of all the proteins in a cell. These multiple separation parameters, including the various forms of chromatographic separation, do not resolve (isolate) the proteins explicitly, but provide for implicit resolution based on a unique combination of positional data for each protein from all the multiple separation parameters taken as a whole.
  • the present invention provides such a means of analysis.
  • This said means allows for the selective recombining by pooling of semi-purified cellular fractions profiled on the above described multiple separation means. These recombined pools are formulated using the positional mapping information so as to include or completely exclude certain specific target proteins from the recombined pool.
  • An additional object of the present invention is to provide a means, using said exact positional mapping, for the systematic deconvolution of the individual sourcesof biological activity measured in these same semi-purified cell protein fractions. This systematic deconvolution of individual sources of biological activity is particularly useful when the biological activity is labile and must be measured immediately after lysing a cell.
  • the ability to implicitly isolate the biological activity of individual target molecules or mixtures of molecules by pooling semi-purified cell protein fractions so as to partially enhance (include) or completely eliminate a given target (exclude) is another key technology of the present invention.
  • This key technology is dependent on complete positional mapping in multiple separation parameters, down to the very lowest abundance, of all proteins in a cellular inventory, which is provided for in the present invention.
  • the nature of the targeted biological activity can be any natural interaction or enzymatic activity of the target molecule, or it can be an artificially created interaction not generally found in a living cell, such as pharmaceutical activity, immunological or artificial binding epitope interaction, or selective artificial enzymatic substrates.
  • a further object of the present invention is to provide a means of scoring, selecting, screening and characterizing said biological activity interactions with many thousands of the target molecules in a cell in parallel and simultaneously so that the biological activities of an array of many target molecule interactions can be analyzed without further physical separation and without interference with one another.
  • a large set of selectively recombined cellular fractions created in pairs for each target molecule in the target set, can be analyzed using any solution based biological assay. Since the biologically active molecules in question would be widely distributed in the various reformulated pools, a modestly positive signal in both the partially enhanced and eliminated pools of some tested pair would not be significant. However, if a pair of said selectively recombined cellular fractions were tested and showed a pattern of increased activity, above that in other pairs in the enhanced pool, and was completely devoid of activity in the pool that completely eliminated a given target, it would indicate a strong correlation between the measured biological activity and the specific target molecule associated with the pair of recombined cellular pools so tested.
  • the present invention provides a means of analysis for natural interactions, among them are biologically significant protein-protein interactions or protein (enzyme)-substrate interactions involved in normal biological activities in living cells.
  • This said method of analysis of the present invention provides for interactions in a native state or conformation, in contrast to the existing art known as two-hybrid or three-hybrid methods (US patent No. 5,283,173 Fields, S. et al. 1994, US patent No. 5,928,868 Liu, Jun et al. 1999) wherein some proximity signal between interacting species is detected.
  • the existing two and three hybrid methods generally involve the artificial over-expression of the proteins to be tested in recombinant expression vectors, such as yeast cells genetically engineered to contain the test protein. These existing two and three hybrid methods represent, at best, a surrogate model of protein-protein interaction far removed from the actual conditions of interaction between native proteins in a living cell.
  • the parallel nature of this directed molecular evolution which we will hereto refer to as "directed molecular co-evolution", allows candidate molecules to be chosen and selected for each interactive target molecule on the basis that they are exceptionally specific for the target molecule and comparatively non-interactive to any other target molecule in the cellular inventory.
  • Such a compendium of co-evolved molecules can subsequently be positionally arrayed either in solution compartments or immobilized to a surface so as to analyze changes in target protein interactions on a global scale.
  • Said compendium of co- evolved molecules may be isolated molecules or may be displayed on the surface of the said surface display expression vectors that created them.
  • This compendium of co-evolved molecules can also be used to create exceptionally specific intracellular tags for the corresponding target molecules (within living cells) following chemical conjugation to a desired functional chemical moiety.
  • the characteristic typically selected for is binding to a target (US Patent 5,403,484 Ladner et al 1993 for example). It is a further object of the present invention to provide a means of scoring the interaction for selection utilizing the method of selective recombination by pooling of cellular fractions described above as a test target and causing a non-denatured potentially active form of the target to be present in enhanced abundance or completely eliminated from a test cellular pool.
  • This object of the present invention increases the nature of the selectable characteristics used in directed molecular evolution of interacting molecules to include any measurable biological activity of the target molecule, not just binding, as is common in the existing art.
  • a novel means of presenting the target set, or molecular fragments from the target set, to all the stochastically generated candidate molecules is another object provided in the current invention.
  • a series of target molecules are immobilized on particles and transferred in a serial fashion from one subset of the stochastically generated molecules to another in such a fashion that relatively weak interactions result in isolating the interacting target/candidate pair.
  • the present invention includes another novel method of selecting and ranking closely related specifically interacting molecules for interaction with a large pool of target or non-target molecules, in this case having only subtle differences in said target or non-target interactions.
  • the present invention relates to a series of methods and apparatus that first determine the positional coordinates of a very large number of naturally occurring or naturally grouped biological molecules such as the cellular inventory of expressed proteins in a living cell at one moment in time, hereafter referred to as the target set. These said positional coordinates are identified for each biological molecule in the target set on a plurality of solution based separation means that distribute the said biological molecules in complimentary (orthogonal) patterns such that a given biological molecule's positional coordinates are unique.
  • the present invention further relates to a method of using this positional coordinate information to recombine a plurality of isolated fractions from a plurality of said solution based separation means in such a fashion that two carefully formulated pools are created for each target molecule in the target set.
  • those said fractions from each solution based separation means that contain a given target molecule are recombined to create a subset pool of the entire target set containing the given target in an enriched manner.
  • Many other target molecules that co-elute in the same said fractions from the same said solution based separation means will be incidentally included.
  • those said fractions from each solution based separation means that do not contain any trace of the given target molecule are recombined to create a subset pool of the entire target set that incidentally includes every molecule in the target set except the target molecule in question. Because of the complimentary (orthogonal) distribution of target molecules between the various solution based separation means, those members of the target set incidentally removed along with the given target molecule from one such solution based separation means will be incidentally included from one or more of the other solution based separation means.
  • the recombining process described herein is informationally complex but physically simple and can be accomplished using existing robotic fluid handling apparatuses.
  • the pairs of recombined subsets of pooled fractions of the entire target set as in the first described case wherein the given target molecule is enhanced, will hereinafter be called the "inclusionary pool”.
  • the pairs in the second described case wherein the given target molecule is excluded, will hereinafter be called the "exclusionary pool”.
  • the pair of inclusionary and exclusionary pools which contain stable biologically active or non-denatured molecules in solution, provide a powerful general analytical tool for correlating measured biological activity to the target molecule in question and they have many applications within the current invention.
  • a further means is provided, using said positional coordinate information from solution based separation means, for the correlation of labile biological activity that can only be measured in whole cell lysates immediately after the breaking or lysing of the cells.
  • the labile biological activity is rapidly profiled and calibrated to fractions of the cell lysate separated in parallel on each of the same said solution based separation means used to create the positional coordinate information.
  • the distribution of the biological activity on each profile is then mathematically fitted to the distribution of each target molecule in order to provide a weighted measure of correlation between the said biological activity and each said target molecule or molecules in the target set.
  • a correlated subset of potential target molecules is created for each separation means.
  • inclusionary and exclusionary pairs provide a further means of correlation of any stable biological activity that can be measured in vitro in the same said inclusionary and exclusionary pairs.
  • This activity can include any biological activity measured against an exogenous substrate, pharmaceutical compound or biological molecule.
  • the method provides for the pair-wise screening of endogenous target molecules for biologically significant target-target interactions by further combinatorial recombination of fractions from the aforementioned solution based separation means.
  • pooling fractions so as to screen each target molecule for biological interaction against all the other target molecules would require the creation of an exceptionally large number of doubly inclusionary and exclusionary pairs. In this case every possible pair of target molecules would be recombined two at a time so that both targets were enhanced and excluded respectively. If the total number of target molecules were 10 3 then there would be 499,500 such double pairs.
  • a means for selecting and screening stochastically generated candidate molecules from stochastic libraries that interact with said exclusionary and inclusionary pools is provided.
  • a stochastic library of candidate molecules expressed on the surface of an expression vector (such as a phage, bacterial cell or yeast cell for instance) is first pre-screened for interaction, to a predetermined level of stringency, against the exclusionary pool (i.e. formulated so as to exclude a particular target molecule) by some means in which the interacting candidate molecule expression vectors are retained or otherwise identified.
  • This pre-screening provides a method by which candidate molecules that are potentially highly specific for the target molecule are enriched in the sub-set of the stochastic library that is not retained.
  • Said enriched sub-set of the stochastic library is subsequently screened for interaction against the inclusionary pool.
  • Retained or otherwise identified candidate molecule vectors are potential candidate molecules for said interaction.
  • This process of exclusionary pre- screening and subsequent inclusionary screening can be repeated for every exclusionary/ inclusionary pair within a target set.
  • the stochastic library can be interacted with said target set in parallel or in a serial fashion.
  • a further means for selecting and screening closely related stochastically generated candidate molecules from stochastic libraries that interact with said exclusionary and inclusionary pools is provided.
  • the process of directed molecular evolution involves biological descent (in this case the clonal expansion of candidate molecule vectors) with variation. This results in many closely related but variant candidate molecules expressed on the surface of their vectors. Each individual vector has only the candidate molecule corresponding to its variant recombinant gene.
  • a means of scoring the relative interaction of said related candidate molecules against a chosen target and additionally, scoring the relative interaction of said related candidate molecules for unwanted interaction with all other target molecules in a target set is a desirable goal in directed molecular evolution.
  • a means of said scoring of relative interaction among closely related variant candidate molecules is provided by attachment of said related candidate molecules or the vectors that display said related candidate molecules to a magnetic particle in the nanometer to micrometer range of sizes.
  • Said magnetic particles are allowed to interact in free solution with the aforementioned exclusionary or inclusionary pools so as to bind those target molecules that interact with said related candidate molecules. This includes very weak interactions with target molecules in the exclusionary pool. Said magnetic particles along with any attached target molecules, are subsequently placed in a mobile solution phase and drawn through a stationary phase medium by application of a magnetic field, thus providing a method for the partitioning of the closely related candidate molecules attached directly or indirectly to the magnetic particles.
  • Said method for the partitioning of related candidate molecules may involve steric hindrance of the nanometer sized magnetic particles through a microporous matrix due to the presence of attached interacting target molecules.
  • a further means of partitioning related candidate molecules is the competitive interaction of target molecules in solution with magnetic particles having related candidate molecules attached and a stationary matrix having relatively weakly interacting candidate molecules or their vectors immobilized on the matrix surface.
  • closely related variant candidate molecules that do not interact with the exclusionary pool i.e. are highly selective for a given target
  • the subset of closely related candidate molecules that travel through the stationary matrix with the least interaction will elute first and represent a subset of closely related variants selected for the trait of non-interaction with the exclusionary pool of target molecules.
  • a final means is provided for the identification of initial candidate molecules from a stochastically generated library of surface display expression vectors wherein the target molecules or fragments of the target molecules in a purified form are covalently attached to nanometer-scale magnetic particles having a smaller size distinguishable from the size of the vectors in said library.
  • the complete stochastic library of candidate molecules is subdivided during its creation into a plurality of sub-libraries, a plurality of compartments or wells. Each sub-library contains a very large number of independently stochastically generated candidate molecules. Due to the astronomical number of potential candidate molecules generated in any stochastic process, there will be few, if any, identical candidate molecules in different sub-libraries.
  • the size and number of candidate molecules in each said sub-library is chosen in order to limit the number of potential initial interactions with a target molecule or set of mixed target molecules. It is desired that less than one positive interaction be recorded during the incubation of each said sub-library with one or more magnetically immobilized target molecules.
  • Said magnetically immobilized target molecules are magnetically drawn into a sub-library and incubated to achieve equilibration of any potential interaction.
  • a microporous screen or sieve is placed over the surface of the compartment containing the sub-library. Said screen or sieve provides a means of retaining all candidate vectors, but allowing the passage of said smaller magnetic particles. Magnetic particles interacting with some candidate molecule on the surface of an expression vector would be retained, while all other magnetic particles were magnetically drawn through the screen or sieve into a new sub-library.
  • retained magnetic particles can be detected in the sub-libraries by sensitive magnetic detectors such as super-conducting quantum interference devices.
  • the set of magnetically immobilized target molecules can be serially passed in this fashion from one sub-library to another.
  • FIG. 1A is a schematic representation depicting a typical solution based separation means time based elution showing a typical profile (for descriptive purposes only) and the position of a plurality of fractions chosen to correspond and calibrate to fractions in a predetermined reference database which is also schematically depicted showing positional information of typical target molecules.
  • FIG. 1 B is a schematic representation depicting a method of combining fractions from a plurality of time based elution profiles from solution based separation means that exclude a particular target molecule based on positional information in a predetermined reference database.
  • FIG. 1C is a schematic representation depicting a method of combining fractions from a plurality of time based elution profiles from solution based separation means that include a particular target molecule based on positional information in a predetermined reference database.
  • FIG. 2 is a schematic representation depicting an apparatus and method for the parallel introduction and separation of a sample on a plurality of solution based separation means and a plurality of fractions in arrays, for collecting the time based elution from said separation means, that correspond to the position of fractions in said predetermined reference database.
  • FIG. 3A is a schematic representation depicting a plotting of one typical biological activity profile as measured in said plurality of fractions in an array and a schematic representation of corresponding fractions in a pre-determined reference database showing corresponding target molecules and a vertical measure of their fit to the biological activity profile. Hypothetical target molecules are labeled A through H, while unlabeled target molecules represent non-correlated target molecules.
  • FIG. 3B is a schematic representation depicting a plotting of a second different profile of the same biological activity as measured in said plurality of fractions in a second array and a schematic representation of corresponding fractions in a pre- determined reference database showing corresponding target molecules and a vertical measure of their fit to the biological activity profile.
  • Hypothetical target molecules are labeled A, C, D, E, G, H, K, and J, while unlabeled target molecules represent non-correlated target molecules.
  • FIG. 3C is a schematic representation depicting a plotting of a third different profile of the same biological activity as measured in said plurality of fractions in a third array and a schematic representation of corresponding fractions in a predetermined reference database showing corresponding target molecules and a vertical measure of their fit to the biological activity profile.
  • Hypothetical target molecules are labeled A, E, F, H, J, K, L, and M while unlabeled target molecules represent non-correlated target molecules.
  • FIG. 3D is a schematic representation depicting a plotting of the intersection of the subset of target molecules in the first subset with the subsets of target molecules in the other subsets, resulting in a best fit target.
  • Hypothetical target molecules are labeled A, B, C, D, E, F, G, H, J, K, L and M while unlabeled target molecules represent non-correlated target molecules, with H representing the best fit target.
  • FIG. 4A is a schematic representation partially depicting a micro-array plate containing sub-libraries of a plurality of stochastically generated surface display expression vectors showing an incubation with target molecules immobilized on paramagnetic particles.
  • FIG. 4B is a schematic representation partially depicting a micro-array plate containing sub-libraries, a microporous screen and a second micro-array plate containing additional sub-libraries.
  • FIG. 4C is a schematic representation depicting a magnetic force field applied perpendicularly to the assembly depicted in FIG. 4B showing the movement and retention of certain paramagnetic particles.
  • FIG. 4D is a schematic representation partially depicting the first micro-array plate containing paramagnetic particles bound to a stochastically generated surface display expression vector, and a removed assembly of a microporous screen and a second micro-array plate containing unbound paramagnetic particles.
  • FIG. 4E is a schematic representation partially depicting the first micro-array plate with non-interacting surface display expression vectors, a magnetic force field applied perpendicularly to the assembly and an aligned empty third micro-array plate showing magnetically transferred paramagnetic particles bound to stochastically generated surface display expression vectors.
  • FIG. 4F is a schematic representation partially depicting the third micro-array plate with the magnetically transferred paramagnetic particles bound to stochastically generated surface display expression vectors showing a schematic representation of a magnetometer for detecting paramagnetic particles.
  • positional coordinate information is determined by the multi-dimensional analysis of a plurality of adjacent fractions along each said solution based separation means of a plurality of such solution based separation means using a large quantity of cell lysate as a reference target set sample.
  • a single ceil type or sub-cellular organelle is used for each positional coordinate mapping target set.
  • each solution based separation means is then divided into many individual fractions according to elution time.
  • Each individual fraction provides a subset of the full target set that contains many individual biological molecules.
  • Said fractions will contain a substantial number of biological molecules that are common to the adjacent fractions in the elution profile providing a contiguous pattern over the total profile.
  • the strategy for this positional mapping involves the pre-fractionation by some sub-cellular isolation means (i.e. nucleus, cytosol, mitochondria etc.), or by some physiochemical criteria such as molecular weight range or isoelectric point range. This allows a sufficient amount of mass to be loaded on said solution-based separation means to detect the lowest abundance biological molecules in the target set.
  • some sub-cellular isolation means i.e. nucleus, cytosol, mitochondria etc.
  • some physiochemical criteria such as molecular weight range or isoelectric point range.
  • fractions are subsequently analyzed by a method that is able to separate all biological molecules in the fraction to near baseline.
  • Said analysis method typically would be a multi-dimensional separation method such as 2D gel electrophoresis or one of the many new "hyphenated” methods of on line analysis such as LC-MS-MS (liquid chromatography-tandem quadrapole mass spectroscopy) as described in "Identifying the major proteome components of Haemophilus influenzae type strain NCTC 8143" Link, A et al. Electrophoresis 18 p1314-1334 (1997).
  • Another method is CIEF-ESI-ICR-MS (capillary isoelectric focusing- electrospray ionization-ion cyclotron resonance mass spectroscopy) described in; "Probing proteomes using capillary isoelectric focusing-electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry" Jensen, PK et al. Analytical Chemistry 71(11) p2076-2084 (1999).
  • a separate multi-dimensional analysis is thus provided for every fraction of a plurality of adjacent fractions on the elution profiles of a plurality of said solution based separation means. Because said adjacent fractions contain many of the same overlapping target molecules, a contiguous mapping of the target molecules along the profile can be calculated by combining the information from each said fraction analysis using prior art imaging techniques such as automated serial segmentation of stacked images.
  • the exact position of all said protein analytes are thus determined along the said plurality of separation means elution profiles in the elution dimension of the separating means.
  • the combined result is a detailed mapping of the positional distribution of every protein analyte in said cell lysate reference sample in multiple dimensions of solution based separation.
  • Said plurality of solution based separation means are chosen to include separation means that are highly complimentary to one another i.e. orthogonal in their separation parameters and thus provide positional distributions of protein analytes that are considerably different from one another. Each protein analyte thus is identifiable by a plurality of positional coordinates in multiple dimensions of solution based separation.
  • the aforementioned solution based separation means include but are not limited to strong and weak cation exchange chromatography, strong and weak anion exchange chromatography, size exclusion chromatography, hydrophobic interaction chromatography, hydrophilic interaction chromatography, hydroxyapatite chromatography, capillary gel electrophoresis, dye interaction chromatography, fast performance liquid chromatography, reverse phase chromatography, perfusion chromatography and low stringency or non-specific affinity chromatography. These methods are well described in the prior art.
  • An alternate embodiment of the present invention includes a means of multidimensional analysis of a plurality of adjacent fractions on a plurality of solution based separation means and is provided by a preferred method of said analysis described in the concurrently filed provisional patent application titled, "A Multi-channel Method and apparatus for solution based Separation and Detection of Amphoteric Substances in Two Dimensions". Said Application (0126-0009 ) was filed 16 November 1999, and is hereby incorporated by reference.
  • each said adjacent fraction on each said solution based separation means represents a single sample for multidimensional analysis and the positional information of individual protein analytes is correlated between adjacent fractions as described above for 2D gel electrophoresis analysis.
  • a sample with a complete cellular inventory or some sub-fraction containing the referenced target set is applied to each said solution based separation means under the same conditions as were used to create said reference database and separated so as to be calibrated to the reference data base with regard to the position of each target molecule.
  • a plurality of fractions of said profiles of said solution based separation means is collected in a manner that protects and preserves biological activity. Said methods of collection include but are not limited to chilled fraction collection in a biological activity stabilizing buffer and or lyophilization with storage below 0° C.
  • FIG.1A the position and order of said plurality of fractions is depicted as calibrated to the position and order of fractions used to create the reference database in such a manner that the inclusion or exclusion of target molecules can be determined for every fraction.
  • an automated liquid handling apparatus is used to withdraw a portion of particular fractions and to transfer and deposit said portion of particular fractions into a new container or tube.
  • Said automated liquid handling apparatus is programmed using the information provided by said reference database to transfer and create as shown in FIG. 1 B a pool (1) in the first case, containing only those fractions (2) from all said profiles that do not contain a particular target molecule and in the second case, FIG. 1 C a pool (3) containing only those fractions (4) that do contain said particular target molecule.
  • the resultant pools (1,3) of a portion of each said fraction from each said profile are referred to as the exclusionary pool (1) and the inclusionary pool (3) to the particular target molecule respectively.
  • Said automated liquid handling apparatus is programmed to repeat the above described procedure of collection, transfer and pooling for every target molecule in said defined target set.
  • the fractional amount taken of each fraction is inversely proportional on the number of target molecules in the target set.
  • the resultant exclusionary and inclusionary pools are either immediately sub-divided into many smaller pools in an array of wells or spotted onto a solid phase or the pools are stored for subsequent sub-division under said conditions that protect and preserve biological activity.
  • the final result is a complex array of biologically active target molecules that can be assayed as a whole system for any particular biological activity that can be measured in solution.
  • a particular biological target molecule responsible in whole or part for the particular assayed biological activity will be incidentally located, along with many other target molecules, in most of the wells or spotted positions of said array.
  • Moderate and comparable activity in both pools of an exclusionary and inclusionary pair does not indicate correlation of the said biological activity to that corresponding target molecule.
  • these comparable signal pairs define a baseline measurement of biological activity that can be used to determine when one or more pairs of exclusionary and inclusionary pools demonstrate a complete lack of biological activity and an enhanced biological activity. Analysis of the position of said enhanced and eliminated biological activity in the array would indicate the identity within the reference database of the responsible target molecule. Subsequent correlation of the responsible target molecule in the reference database to known target molecules in existing molecular databases would provide absolute identification of the target responsible for the measured biological activity.
  • measurable biological activity assays that are stable with time or can preserve said biological activity for a period of time under suitable conditions.
  • an allosteric isoenzyme such as alcohol dehydrogenase 2 (ADH2) in the yeast S. cerevisiae, which catalyses the conversion of ethanol into acetaldehyde
  • ADH2 alcohol dehydrogenase 2
  • yeast S. cerevisiae which catalyses the conversion of ethanol into acetaldehyde
  • There are many other biologically measurable activities that can only be measured in living cells or in solution for a short time after the lysing of the cell. Many such labile activities involve biological activities that require physical interaction by several loosely held subunits that can diffuse away from one another after lysing the cell into a buffering solution.
  • Examples include the kinase activity of many enzymes such as phosphatidly innositol 3 kinase (PI3K). These labile biological activities are not well suited for correlation to target molecules in our positionally mapped reference database by the assay of biological activity in exclusionary/ inclusionary pairs.
  • An alternate method of correlation is provided for in the present invention by means of a calibrated plurality of rapid and/or small scale solution based separation means (see FIG. 2) that correspond in the distribution profile to the larger scale solution based separation means used to create the aforementioned reference database of the target set from the particular cell type being assayed.
  • FIG. 2 depicts said plurality of rapid and/or small scale solution based separation means (5,6,7) corresponding to complimentary chromatographic separation columns as described above.
  • Said solution based separation means are provided, in the usual manner of chromatographic workstations, with a source of hydraulic flow of a suitable mobile phase (8,9,10) for each separation means and a means of introducing the sample into said mobile phases.
  • said means (11) of introducing the sample into each mobile phase will introduce an equivalent sample into each mobile phase at the same time, thus reducing the time required to separate the sample on the various solution based separation means (5,6,7).
  • a plurality of fractions, collected in arrays(12,13,14), of the elution from each said solution based separation means (5,6,7) are simultaneously and rapidly assayed for the particular biological activity being investigated.
  • the scale and speed of said separation and assay is such that a profile of the particular biological activity in question can be obtained within the biological activity lifetime of said biological activity.
  • the measured quantity of biological activity in each said fraction in said first array (12) is recorded so as to determine its maxima and distribution profile as depicted in FIG. 3A.
  • the calibrated maxima and distribution profile of each target molecule in the reference database target set corresponding to those fractions that contain biological activity are, in a preferred embodiment, automatically analyzed using a suitable peak analysis computer program such as
  • PeakFit ® PeakFit ® (SPSS Inc., Chicago, IL.). Said target molecules represent a subset of the entire target set. The relative fit between the maxima and distribution profile of said biological activity and the maxima and distribution profile of each said target molecule in said target subsets is measured and recorded by any suitable means, such as the method of sums of squares of the difference between the compared profiles.
  • said relative fit values of a plurality of hypothetical target molecules is shown (15) vertically plotted as they may have appeared in the aforementioned multi-dimensional analysis method used to analyze and resolve target molecules in the original positionally mapped reference database. Those with the best fit show the highest correlation measurement in the vertical dimension.
  • equivalent biological activity maxima and distribution profiles of the same assayed activity are plotted (13,14) and the corresponding relative fit values calculated for target molecules in the various fractions containing biological activity are again plotted (16,17). It should be noted that most of the target molecules in each said correlation are incidentally correlated to the biological activity purely by chance.
  • the method described provides for the rapid correlation of a measurable labile biological activity to identifiable target molecules in a reference database with only a single and rapid stage of partial purification.
  • Combinatorial libraries containing a multitude of variant small molecules are a valuable new tool for drug discovery.
  • Such combinatorial libraries represent a rich potential source or compounds, called pharmacophores, that interact with the active site of enzymes or signaling molecules in living organisms.
  • pharmacophores that interact with the active site of enzymes or signaling molecules in living organisms.
  • Global knowledge of the interaction of any said variant small molecules with particular target molecules in a cellular lysate is of great potential interest to the drug discovery industry. This information would provide leads for possible pharmacophores within the library before a particular target is defined. Additionally, potential non-specific interactions as well as agonist and antagonist relationships between the said small molecules could be elucidated.
  • a means is provided to globally test a plurality of variant small molecules for interaction with particular target molecules in a target set such as the entire protein inventory of a cell lysate using the aforementioned method of formulating pairs of exclusionary/ inclusionary cell lysate pools.
  • Said method can test said plurality of variant small molecules one at a time against all said pairs of exclusionary/ inclusionary cell lysate pools or more efficiently in groups. Since the rate of positive interaction with any given pair of said pools is likely to be very low, grouping many variant small molecules in a single test is desirable.
  • the number of said variant small molecules tested together should provide a rate of positive interaction of said variant small molecules and said pairs of exclusionary/ inclusionary cell lysate pools, that is less than one per pair. Preferably, a rate of positive interaction less than one in ten to one in one hundred pairs is desirable. In order to prevent double positives within a single test.
  • a plurality of biologically active or non-denatured target molecules is provided, such as proteins formulated from a plurality of fractions separated by a plurality of solution base separation means in the manner describe previously in the current patent.
  • Said formulation provides for said plurality of recombined exclusionary and inclusionary pools.
  • a test is defined herein as the incubation of one or a plurality of variant small molecules at one time with two wells of said array containing an exclusionary pool and an inclusionary pool corresponding to one target molecule in the target set. Many such tests can be performed simultaneously in the current invention.
  • the method of measuring interaction between said variant small molecules and a said pool will be determined by the nature of the combinatorial library and the manner in which it is formulated.
  • the variant small molecules contained in the combinatorial library are labeled with detectable isotopes of the elements found in the combinatorial library.
  • a means of separating interacting small molecules from non interacting small molecules or for measuring proximity between said target molecules and said variant small molecules is provided. Said means include but are not limited to differential filtration, adsorption or sedimentation and proximity scintillation techniques suitable for many small scale tests.
  • a positive test is determined by the measurement of a relatively strong interaction of the test small molecules with the inclusionary pool and a concomitant measurement of little or no interaction with the exclusionary pool. Measurement of a moderate amount of interaction with both pools is not indicative of a positive result as many target molecules will be incidentally included in a given pair that are not the particular target molecule formulated to be included and excluded in said pair. In the case of a positive test where more than one variant small molecule is tested at one time, additional tests can be performed to identify the particular variant small molecule responsible.
  • test of the target protein in its native state provides a global means of measuring actual biological interaction between target molecules in a target set such as the complete cellular protein inventory of a cell type. Said test of the target protein in its native state is provided for with the aforementioned method of pairs of exclusionary/ inclusionary cell lysate pools
  • kinase An enzyme that phosphorylates another substrate protein is called a kinase.
  • Such interaction is often a signal transfer step involved in a signal cascade in which a small initial signal such a receptor activation is propagated and amplified.
  • the phosphorylation enzyme-substrate relationships between proteins are known to be very specific and depend on interaction between particular pairs of kinases and substrates. Discovering the specific kinase-substrate relationships within a target set such as the complete cellular inventory of proteins is a goal of the current example.
  • a means is provided to globally test in vitro a plurality of target molecules within a target set, such as the entire protein inventory of a cell lysate, for kinase-substrate relationships under native conditions.
  • An extension of the method of formulating pairs of exclusionary/ inclusionary cell lysate pools provides a means of testing all target molecules in a target set against all others for enzyme- substrate relationships, in this case the ability to covalently attach a radio-labeled phosphate group to some target molecule within a test pair of said recombined cell lysate pools.
  • a means is provided to formulate an array of doubly inclusive and exclusive cell lysate pools using robotic liquid handling apparatus in which (in contrast to the previously described means) not one but two target molecules from a target set are included and excluded by careful pooling of fractions from the same said solution based separation means used to create single target molecule inclusive and exclusive pools.
  • said doubly inclusive and exclusive cell lysate pools are created utilizing the target positional information provided by the aforementioned comprehensive multi-dimensional mapping reference database.
  • a plurality of doubly inclusive and exclusive cell lysate pools are subsequently tested in the current example by incubation of said doubly inclusive and exclusive cell lysate pools with a suitable phosphate substrate for said kinases that can be incorporated into a substrate target molecule in the target set.
  • a positive test is defined, in the current example, as the determination of covalently bound phosphate in said doubly inclusive cell lysate pool with a concomitant reduction or total lack of covalently bound phosphate in said doubly exclusive cell lysate pool.
  • said phosphate substrate is provided as radiolabeled phosphorous in the ⁇ phosphate position of adenosine triphosphate that is detectable by existing means of radioactive detection.
  • a means is provided to segregate unincorporated adenosine triphosphate from covalently bound phosphate. Said means include but are not limited to differential filtration, adsorption or sedimentation and proximity scintillation techniques suitable for many small scale tests.
  • a related method to quickly optimize the discovery of said kinase-substrate relationships in complex target sets such as the complete cellular protein inventory of a cell type is provided. Said related method narrows candidates for said kinase- substrate relationships to subsets of the overall target set. This allows for subsequent application of the aforementioned method of doubly exclusive and inclusive pools to elucidate the particular target molecule within said target molecule subset only.
  • target sets such as the complete cellular protein inventory of a cell type
  • the number of pairs of target molecules combined in doubly exclusive and inclusive pairs can be impractical to test pair-wise two at a time.
  • the number of said positive tests can be inefficiently low.
  • Said related method of formulating recombined cell lysate pools provides for an initial low stringency test in which a plurality of target molecules are identified as a subset of the complete target set.
  • robotic liquid handling apparatus recombines said fractions from solution based separation means so as to formulate a pool of fractions that specifically excludes all said plurality of target molecules of said subset.
  • a recombined pool of fractions from solution based separation means is formulated that specifically includes all said plurality of target molecules.
  • a means is provided, as before, to test the exclusionary and inclusionary pools corresponding to said subset of said plurality of target molecules.
  • a positive result in the current example, is defined as the determination of covalently bound phosphate in said subset inclusive cell lysate pool with a concomitant reduction or total lack of covalently bound phosphate in said subset exclusive cell lysate pool.
  • a moderate signal in both said pools is inconclusive and does not constitute a positive test.
  • a positive test for a given subset of a plurality of target molecules provides information that one or more pairs of target molecules within said subset plurality of target molecules have a kinase-substrate relationship without determining which pairs are responsible.
  • Said positive test allows for formulating doubly exclusive and inclusive pools with those target molecules within the positive testing subset only.
  • Said formulation of said subset exclusive and inclusive pools allows for additional testing with the method of said doubly exclusive and inclusive pools to eliminate ambiguity about the identity of the pair or pairs of target molecules within said subset responsible for said positive test.
  • a stochastically generated plurality of expressed peptide sequences that provide a means of correlation of the said peptide sequence to the genetic sequence encoded in the vector that expresses said peptide sequence is provided.
  • Each said sequence is by some means displayed on the surface of said genetic vector responsible for said peptide sequence.
  • Said vectors are generally known as surface display expression vectors.
  • the screening of said surface display expression vectors to identify ligands for target molecules such as proteins followed by a process of clonal expansion of said vectors with variation is generally known as directed molecular evolution.
  • a means is provided in the present invention to screen and discover a plurality of stochastically generated surface display expression vectors, that interact through the specific variant peptide sequences so displayed, with specific target molecules in a target set by any means of biological assay that is stable in vitro in a recombined pool of cellular fractions, wherein the said specific variant peptide sequence causes a measurable biological effect.
  • a means for selecting and screening stochastically generated candidate molecules from stochastic libraries of said surface display expression vectors that interact by binding to target molecules within aforementioned exclusionary and inclusionary pools is provided.
  • a means for selecting and screening stochastically generated candidate molecules from stochastic libraries of said surface display expression vectors that interact so as to chemically modify said stochastically generated candidate molecules in a detectable manner is provided.
  • a positive test is determined by the preincubation of said plurality of stochastically generated surface display expression vectors with the exclusionary pool of a pair of exclusionary-inclusionary pools of target molecules.
  • the subset of preincubated stochastically generated surface display expression vectors that do not interact and are unbound to any target molecules within the exclusionary pool is recovered by any of the aforementioned means of bound to unbound separation.
  • Said recovered subset of preincubated stochastically generated surface display expression vectors is subsequently incubated with said inclusionary pool of target molecules.
  • a means of separating bound from unbound stochastically generated surface display expression vectors in said inclusionary pool target set is provided.
  • Said positive test in the current example, is represented by the binding of one or a plurality of surface display expression vectors to target proteins in the inclusionary pool to form a second subset of surface display expression vectors that are candidates for specific interaction with the particular target molecule for which the exclusionary and inclusionary pools were formulated.
  • said second subset represents an enriched subset of potential ligands for clonal expansion and further rounds of screening and discovery.
  • Those potential ligands so discovered are candidate molecules for specific interaction with said particular target molecule for which the exclusionary and inclusionary pools were formulated in the presence of all the other target molecules within the target set.
  • a means is provided to simultaneously screen and discover potentially interactive molecules for every pair of exclusionary and inclusionary pools in a given target set through a plurality of rounds of clonal expansion of said subsets of surface display expression vectors such that non-specific or cross-reactive interactions are selected against.
  • test interaction between surface display expression vectors and exclusionary and inclusionary pools formulated for a particular target molecule involves a chemical modification of the variant peptide of said surface display expression vectors
  • a means is provided to recover and detect said chemical modification after interaction with a test exclusionary and inclusionary pool.
  • screening and discovery of variant peptides of surface display expression vectors that function as potential specific exogenous kinase substrates for particular target molecules is provided. Incorporation of radiolabeled phosphate into the surface display expression vector is measured and detected as described above for endogenous target-target interaction.
  • a positive test indicating a potentially specific kinase substrate for a particular target molecule involves, first, a measurement of radiolabeled phosphate incorporation into said surface display expression vectors following incubation with the inclusionary pool formulated for said particular target molecule. Second, it involves a measurement of little or no radiolabeled phosphate incorporation into said surface display expression vectors following incubation with the exclusionary pool formulated for said particular target molecule. As before, non-differential measurements in both exclusionary and inclusionary pools are inconclusive and represent a negative test result. Additional tests following clonal expansion with variation are greatly enhanced by the selection and separation of said radiolabeled surface display expression vectors.
  • said phosphorylated surface display expression vectors are separated from non-phosphorylated surface display expression vectors using the known art of immunoaffinity separation with phosphorylated peptide specific antibodies.
  • the current examples of screening and discovery of interactive peptides form stochastically generated surface display expression vectors that interact with a complete target set provide for the identification of initial candidate molecules only.
  • a program of simultaneous directed molecular evolution or directed molecular co- evolution requires a further means of scoring said initial candidate molecules for subtle differences in their interaction with a particular target molecule and for subtle differences in their unwanted interaction with non-target molecules.
  • a means is provided to partition a plurality of related or unrelated initially selected candidate molecules in a stochastically generated library of surface display expression vectors on the basis of subtle differences of interaction with said particular target molecule for which they were initially selected and for subtle differences of interaction with said non-target molecules for which they were initially selected against.
  • a means is provided to covalently immobilize said variant peptide sequences, as displayed on said surface display expression vectors, or as isolated peptides onto a paramagnetic particle having dimensions in the nanometer to micrometer range. Said paramagnetic particle will move by magnetic force in an externally applied magnetic force field.
  • a plurality of initial candidate molecules are so immobilized in separate immobilization reactions such that a single candidate molecule is present on the paramagnetic particles within a compartment. After said separate immobilization reactions, said paramagnetic particles with all initial candidate molecules are mixed to form a single pool of paramagnetic particles.
  • Said pool of paramagnetic particles can be subdivided to provide multiple test pools to the extent that each initial candidate molecule is represented in each said subdivided multiple test pool.
  • Said single pool of paramagnetic particles is incubated with an exclusionary target set pool formulated as described above to contain all target molecules except the particular target molecule for which the initial candidate interactive molecule has been selected.
  • Possible non-specific or low affinity interaction of said immobilized candidate molecule with non-target molecules in said exclusionary target set pool results in a loosely associated molecular complex surrounding the paramagnetic particle.
  • Said paramagnetic particle and its immobilized candidate ligand is partitioned between a stationary phase, such as a porous matrix, by differences in the resistance to an applied magnetic force field cause by a differences in the partition coefficient of said paramagnetic particles.
  • said partition is provided by differences in the mobility of said paramagnetic particle due to size or steric hindrance of any said loosely associated molecular complex.
  • Paramagnetic particles having little or no interaction with non-target molecules in said target set will exhibit the least resistance to movement by the said externally applied magnetic force field and will thus segregate ahead of the paramagnetic particles that do exhibit non-specific interaction, however subtle, with the non-target molecules in said target set.
  • a further means of segregating or fractionating the paramagnetic particle stream so as to isolate the various paramagnetic particles with immobilized initial candidate molecules is provided.
  • Information is thus determined to allow the relative scoring of specificity towards a particular target molecule of an initial variant candidate molecule from a stochastically generated library.
  • Variant candidate molecules in additional rounds of clonal expansion with variation can also be scored in this fashion.
  • the previous examples of discovery of candidate molecules from a stochastically generated library of surface display expression vectors generally involve formulation of target molecule pools in solution.
  • an efficient means is provided to select initial candidate binding ligands to all target molecules in a target set wherein the particular target molecule is isolated and immobilized onto a paramagnetic particle.
  • Said paramagnetic particle is preferably in the nanometer size range, but in a size range distinguishable from the size of the said surface display expression vector used to generate said stochastic library.
  • a source of isolated target molecules or fragments of said isolated target molecules such as proteins and peptide fragments of isolated target molecules is provided. Said isolated target molecules are separately immobilized onto paramagnetic particles using any means of covalent attachment.
  • a stochastically generated library of candidate ligands expressed on the surface of a micrometer scale surface display expression vector such as a recombinant yeast vector is provided.
  • said stochastically generated surface display expression vectors are divided during construction into a plurality of sub-libraries containing unique stochastic subsets.
  • each said sub-library (18) is isolated into a single compartment or well in a micro- array plate (19).
  • a means of rapid and efficient massively parallel discovery of initial candidate ligands to all target molecules in a target set is provided.
  • Said isolated target molecules (20) are separately immobilized onto paramagnetic particles (21).
  • Said paramagnetic particles are incubated in a single said sub-library (18) of said stochastically generated surface display expression vectors (22).
  • a microporous screen (23) is placed over said micro-array plate (19).
  • Said microporous screen hole size is such that the said paramagnetic particles (21) can easily pass through but said surface display expression vector (22) is completely retained.
  • a second micro-array plate (24) having additional sub-libraries is placed over said incubated micro-array plate (19) containing the equilibrated incubation test such that the wells in one micro-array plate align with the wells in the other micro- array plate.
  • a magnetic force field (25) is externally applied perpendicular to the faces of the combined micro-array plates as shown in FIG. 4C so as to move the non- interacting paramagnetic particles (21) into the second micro-array plate (24).
  • Interacting paramagnetic particles (26) bound to surface display expression vectors (27) will be held back from transfer and retained in said first micro-array plate (19) because the interacting surface display expression vector (27) cannot pass through said microporous screen (23).
  • said magnetic force field (25) is removed and said first micro-array plate (19) is removed from the assembly (28) of said microporous screen (23) and said second micro-array plate (24).
  • a third empty micro- array plate (29) as shown in FIG.4E, for collecting any interacting magnetic particles is placed over said first micro-array plate (19) without any microporous screen, again with alignment of wells between the two plates.
  • a magnetic force field (25) is again externally applied perpendicular to the faces of the combined micro-array plates (19, 29) so as to move the interacting paramagnetic particles (26) and any attached surface display expression vectors (27) into said empty third micro-array plate (29).
  • said magnetic force field (25) is removed and said third micro- array plate (29) containing potential candidate surface display expression vector (27) is analyzed for the presence of a bound paramagnetic particle (26).
  • the paramagnetic particle (26) is detected by a magnetometer (30) in a weak magnetic field such as the Earth's magnetic field.
  • a magnetometer is a super-conducting quantum interference device.
  • the non-interacting paramagnetic particles (21) of the first test are subsequently incubated and tested in a like manner in the sub-library of the second micro-array plate (24).
  • a plurality of target molecules are serially passed from one sub-library of surface display expression vectors to another to test for interaction.
  • a plurality of target molecules bound to paramagnetic particles are thus tested in a massively parallel fashion for discovery of interaction with some initial stochastically generated candidate molecule in a specific sub-library.
  • the initial candidate molecule is segregated from said sub-library and collected for subsequent rounds of clonal expansion and interaction with said particular target molecule.
  • a means is provided to allow every target molecule to incubate and be tested against every said sub-library in a serial manner.
  • combinatorial sets of unrelated target molecules on said paramagnetic particles are mixed in a plurality of semi-replicate pools such that no two replicate pools contain more than one common target molecule.
  • a positive test will reveal a pattern of replicate positives in a subset of said replicate pools corresponding to the subset of pools containing the source of the positive test. In this manner the identity of the particular positive target molecule is revealed by the combinatorially determined intersects of the various replicate pools.
  • the number of combined tests can be greatly increased. It should be noted, however, that more than one positive result within a single combined test will be ambiguous as to the identity of the interacting target due to the detection of more than the standard number of positives within the replicate pool set. Said ambiguity is minor and easily eliminated by further testing.

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention a trait au domaine de la protéomique. Elle concerne notamment des procédés et des dispositifs pour l'isolement, la caractérisation, le tri, la recombinaison et l'interaction de molécules biologiques telles que protéines, peptides, acides nucléiques et ligands, de manière à analyser différentes activités biologiques de ces molécules, prises individuellement ou au niveau cellulaire. En outre, l'invention concerne l'établissement d'un relevé topologique de molécules biologiques isolées dans des éléments de séparation à base de solutions multiples, en vue de constituer un ensemble unique de caractéristiques identifiant chaque molécule biologique dans un système. L'invention concerne également l'utilisation de ces informations pour le tri, la sélection et l'enrichissement simultanés de ligands interactifs, substrats interactifs ou autres molécules interactives parmi des milliers d'interactions biologiques parallèles entre ligand et cible, substrat et enzyme ou autre. L'invention concerne aussi l'identification et la mise en évidence de molécules cible ou interactives, destinées à être analysées ultérieurement. L'invention est utile dans le tri et l'étude de petites molécules potentiellement thérapeutiques ainsi que leurs interactions dans différents types de cellules.
PCT/US1999/027192 1998-11-17 1999-11-17 Separation, tri et identification de cibles biologiques WO2000029848A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU20254/00A AU2025400A (en) 1998-11-17 1999-11-17 Separation, screening, and identification of biological targets

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10888998P 1998-11-17 1998-11-17
US60/108,889 1998-11-17

Publications (2)

Publication Number Publication Date
WO2000029848A1 true WO2000029848A1 (fr) 2000-05-25
WO2000029848A9 WO2000029848A9 (fr) 2000-11-09

Family

ID=22324653

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/027192 WO2000029848A1 (fr) 1998-11-17 1999-11-17 Separation, tri et identification de cibles biologiques

Country Status (2)

Country Link
AU (1) AU2025400A (fr)
WO (1) WO2000029848A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002021137A1 (fr) * 2000-09-04 2002-03-14 Meltec Multi-Epitope-Ligand-Technologies Gmbh Procede pour identifier des proteines specifiques de cellules
US6579720B1 (en) * 1999-05-13 2003-06-17 Bdc Pharma Llc Method for activity profiling compound mixtures
WO2003062462A2 (fr) * 2002-01-16 2003-07-31 Dynal Biotech Asa Methode permettant d'isoler des acides nucleiques et des proteines contenus dans un echantillon unique
EP1576183A2 (fr) * 2001-02-16 2005-09-21 Ciphergen Biosystems, Inc. Procede de correlation de profils d'expression de genes avec des profils d'expression de proteines
US7229762B2 (en) 2002-10-15 2007-06-12 Duke University Medical Center Proteomic screening for redox state dependent protein—protein interactions
US7358043B2 (en) 2001-10-16 2008-04-15 Duke University Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
CN104965998A (zh) * 2015-05-29 2015-10-07 华中农业大学 多靶标药物和/或药物组合的筛选方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425138D0 (en) 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4790919A (en) * 1984-06-28 1988-12-13 E. I. Du Pont De Nemours And Company Process for preparation of electrophoresis gel material

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4790919A (en) * 1984-06-28 1988-12-13 E. I. Du Pont De Nemours And Company Process for preparation of electrophoresis gel material

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BINZ ET AL.: "A Molecular Scanner to Automate Proteomic Research and To Display Proteome Images", ANAL. CHEM.,, vol. 71, no. 21, 1 December 1999 (1999-12-01), pages 4981 - 4988, XP002923560 *
FELICI ET AL.: "Phage-Displayed peptides as Tools for Characterization of Human Sera", METHODS IN ENZYMOLOGY,, vol. 267, 1996, pages 116 - 129, XP002923561 *
GYGI ET AL.: "Correlation Between Protein and mRNA Abundance in Yeast", MOLECULAR AND CELLULAR BIOLOGY,, vol. 19, no. 3, March 1999 (1999-03-01), pages 1720 - 1730, XP002923559 *
WILKINS ET AL.: "From Proteins to Proteomes: Large Scale Protein Identification by Two-Dimensional Electrophoresis and Amino Acid Analysis", BIO/TECHNOLOGY,, vol. 14, January 1996 (1996-01-01), pages 61 - 65, XP002923558 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579720B1 (en) * 1999-05-13 2003-06-17 Bdc Pharma Llc Method for activity profiling compound mixtures
WO2002021137A1 (fr) * 2000-09-04 2002-03-14 Meltec Multi-Epitope-Ligand-Technologies Gmbh Procede pour identifier des proteines specifiques de cellules
US7676328B2 (en) 2000-09-04 2010-03-09 Mpb Meltec Patent-Und Beteiligungsgesellschaft Mbh Method for identifying cell-specific proteins
EP1576183A2 (fr) * 2001-02-16 2005-09-21 Ciphergen Biosystems, Inc. Procede de correlation de profils d'expression de genes avec des profils d'expression de proteines
EP1576183A4 (fr) * 2001-02-16 2005-09-21 Ciphergen Biosystems Inc Procede de correlation de profils d'expression de genes avec des profils d'expression de proteines
US7299134B2 (en) 2001-02-16 2007-11-20 Bio-Rad Laboratories, Inc. Method for correlating gene expression profiles with protein expression profiles
US7358043B2 (en) 2001-10-16 2008-04-15 Duke University Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
US8039217B2 (en) 2001-10-16 2011-10-18 Duke University Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
WO2003062462A2 (fr) * 2002-01-16 2003-07-31 Dynal Biotech Asa Methode permettant d'isoler des acides nucleiques et des proteines contenus dans un echantillon unique
WO2003062462A3 (fr) * 2002-01-16 2003-12-11 Dynal Biotech Asa Methode permettant d'isoler des acides nucleiques et des proteines contenus dans un echantillon unique
US7229762B2 (en) 2002-10-15 2007-06-12 Duke University Medical Center Proteomic screening for redox state dependent protein—protein interactions
CN104965998A (zh) * 2015-05-29 2015-10-07 华中农业大学 多靶标药物和/或药物组合的筛选方法

Also Published As

Publication number Publication date
AU2025400A (en) 2000-06-05
WO2000029848A9 (fr) 2000-11-09

Similar Documents

Publication Publication Date Title
Poetz et al. Protein microarrays: catching the proteome
Ong et al. An evaluation of the use of two-dimensional gel electrophoresis in proteomics
Ahmad et al. B-cell epitope mapping for the design of vaccines and effective diagnostics
Godovac‐Zimmermann et al. Perspectives for mass spectrometry and functional proteomics
Lenz et al. Chemical ligands, genomics and drug discovery
Graves et al. Molecular biologist's guide to proteomics
Haynes et al. Proteome profiling—pitfalls and progress
Yanagida Functional proteomics; current achievements
Bevan et al. Identifying small-molecule lead compounds: the screening approach to drug discovery
Patterson et al. Proteomics: the first decade and beyond
Mumby et al. Phosphoproteomics: new insights into cellular signaling
US20020012920A1 (en) Method and kit for proteomic identification
White et al. Methods for the analysis of protein phosphorylation–mediated cellular signaling networks
Legrain et al. From the analysis of protein complexes to proteome-wide linkage maps
Loo Mass spectrometry in the combinatorial chemistry revolution
Bradshaw et al. From proteins to proteomics
Furka Forty years of combinatorial technology
Katayama et al. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography
WO2000029848A1 (fr) Separation, tri et identification de cibles biologiques
Whiteaker et al. Peptide immunoaffinity enrichment with targeted mass spectrometry: application to quantification of ATM kinase phospho-signaling
Rappsilber et al. Is mass spectrometry ready for proteome-wide protein expression analysis?
Reddy et al. Proteomics in transfusion medicine.
EP3566052A1 (fr) Essais de liaison de ligands utilisant la spectrométrie de masse maldi-tof
Ali‐Khan et al. Overview of proteome analysis
US20030013138A1 (en) Systems and methods for the analysis of proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/8-8/8, DRAWINGS, REPLACED BY NEW PAGES 1/8-8/8; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase